Conclusion Employers must consider many factors, including costs, compliance, and employee expectations, when determining whether to offer GLP-1 coverage under the health plans they sponsor
Build the habits now while conditions favor success
These include methotrexate as first-line therapy, with escalation to combination conventional synthetic DMARDs or biological agents if disease activity remains inadequately controlled
In contrast, unregistered and online pharmacies may offer unsafe products that can be harmful
Its part of a group of GLP-1 type 2 diabetes drugs
What to keep in mind: TrimRx offers both GLP-1 (semaglutide) and GLP-1 + GIP (tirzepatide) options, giving you flexibility depending on what your clinician recommends